Cargando…

Immunoglobulin G1 Antibodies Against Phosphorylcholine Are Associated With Protection in Systemic Lupus Erythematosus and Atherosclerosis: Potential Underlying Mechanisms

OBJECTIVE: Immunoglobulin M antibodies against phosphorylcholine (anti‐PCs) may be protective in atherosclerosis, cardiovascular disease (CVD), and systemic lupus erythematosus (SLE). We study immunoglobulin G1 (IgG1) and immunoglobulin G2 (IgG2) anti‐PCs, with a focus on atherosclerosis and SLE. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thiagarajan, D., Fiskesund, R., Frostegård, A., Steen, J., Rahman, M., Vikström, M., Lundström, S., Frostegård, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301871/ https://www.ncbi.nlm.nih.gov/pubmed/32392632 http://dx.doi.org/10.1002/acr2.11127

Ejemplares similares

Antibodies against Native and Oxidized Cardiolipin and Phosphatidylserine and Phosphorylcholine in Atherosclerosis Development
por: Frostegård, Anna G., et al.
Publicado: (2014)

Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus
por: Anania, Cristina, et al.
Publicado: (2010)

IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases
por: Thiagarajan, Divya, et al.
Publicado: (2020)

Antibodies against Phosphorylcholine—Implications for Chronic Inflammatory Diseases
por: Frostegård, Johan
Publicado: (2023)

Different subclasses and isotypes of antibodies against phosphorylcholine in haemodialysis patients: association with mortality
por: Samal, S. K., et al.
Publicado: (2020)

Antibodies Against Phosphorylcholine Among 60-Year-Olds: Clinical Role and Simulated Interactions
por: Samal, Shailesh Kumar, et al.
Publicado: (2022)

IgM-Antibodies against Phosphorylcholine in Mothers and Normal or Low Birth Weight Term Newborn Infants
por: Frostegård, Anna G., et al.
Publicado: (2014)

Systemic lupus erythematosus and cardiovascular disease
por: Frostegård, Johan
Publicado: (2022)

Antibodies against phosphorylcholine in hospitalized versus non-hospitalized obese subjects
por: Jujić, Amra, et al.
Publicado: (2021)

Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study
por: Ajeganova, Sofia, et al.
Publicado: (2015)

Anti-high-density lipoprotein antibodies and lipoprotein characteristics in systemic lupus erythematosus-related cardiovascular disease
por: Su, J, et al.
Publicado: (2005)

Human IgM Antibodies to Malondialdehyde Conjugated With Albumin Are Negatively Associated With Cardiovascular Disease Among 60‐Year‐Olds
por: Thiagarajan, Divya, et al.
Publicado: (2016)

Identification of IgG1 isotype phosphorylcholine antibodies for the treatment of inflammatory cardiovascular diseases
por: de Vries, M. R., et al.
Publicado: (2021)

Non-traditional risk and protective factors for cardiovascular disease in systemic lupus erythematosus
por: Cederholm, A, et al.
Publicado: (2005)

IgM antibodies to oxidized phosphatidylserine as protection markers in cardiovascular disease among 60-year olds
por: Frostegård, Johan, et al.
Publicado: (2017)

Endothelial function and activation in women with systemic lupus erythematosus
por: Svenungsson, E, et al.
Publicado: (2005)

Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study
por: Elkan, Ann-Charlotte, et al.
Publicado: (2009)

Atheroprotective natural anti-phosphorylcholine antibodies of IgM subclass are decreased in Swedish controls as compared to non-westernized individuals from New Guinea
por: Frostegård, Johan, et al.
Publicado: (2007)

Higher levels of anti-phosphorylcholine autoantibodies in early rheumatoid arthritis indicate lower risk of incident cardiovascular events
por: Ajeganova, Sofia, et al.
Publicado: (2021)

Immunity, atherosclerosis and cardiovascular disease
por: Frostegård, Johan
Publicado: (2013)

Immune Mechanisms in Atherosclerosis, Especially in Diabetes Type 2
por: Frostegård, Johan
Publicado: (2013)

Gluten-free vegan diet induces decreased LDL and oxidized LDL levels and raised atheroprotective natural antibodies against phosphorylcholine in patients with rheumatoid arthritis: a randomized study
por: Elkan, Ann-Charlotte, et al.
Publicado: (2008)

Targeting Phosphorylcholine in Established Atherosclerosis?
por: Tsiantoulas, Dimitrios
Publicado: (2020)

Variation in pain related to systemic lupus erythematosus (SLE): a 7-year follow-up study
por: Waldheim, Eva, et al.
Publicado: (2018)

Antibodies against malondialdehyde among 60-year-olds: prediction of cardiovascular disease
por: Samal, Shailesh Kumar, et al.
Publicado: (2023)

Antibodies against oxidation-specific epitopes and risk of acute myocardial infarction
por: Frostegård, Johan
Publicado: (2023)

Decreased binding of annexin V to endothelial cells: a novel mechanism of atherothrombosis in patients with systemic lupus erythematosus
por: Cederholm, A, et al.
Publicado: (2005)

Effects of Atorvastatin on T‐Cell Activation and Apoptosis in Systemic Lupus Erythematosus and Novel Simulated Interactions With C‐Reactive Protein and Interleukin 6
por: Sun, Jitong, et al.
Publicado: (2021)

Intravenous Immunoglobulin in the Management of Lupus Erythematosus Panniculitis
por: AlQadri, Nada G, et al.
Publicado: (2020)

Aortic Atherosclerosis in Systemic Lupus Erythematosus
por: Roldan, Paola C, et al.
Publicado: (2014)

Potential natural immunization against atherosclerosis in hibernating bears
por: Samal, Shailesh Kumar, et al.
Publicado: (2021)

Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
por: Floris, Alberto, et al.
Publicado: (2018)

Hydroxyl Radical Modification of Immunoglobulin G Generated Cross-Reactive Antibodies: Its Potential Role in Systemic Lupus Erythematosus
por: Al-Shobaili, Hani A., et al.
Publicado: (2011)

Low levels of IgM antibodies to oxidized cardiolipin increase and high levels decrease risk of cardiovascular disease among 60-year olds: a prospective study
por: Su, Jun, et al.
Publicado: (2013)

Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae
Publicado: (1982)

Role of Hepatic Deposited Immunoglobulin G in the Pathogenesis of Liver Damage in Systemic Lupus Erythematosus
por: Fang, Xiang, et al.
Publicado: (2018)

Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis
por: Teixeira, Vítor, et al.
Publicado: (2018)

Systemic lupus erythematosus aggravates atherosclerosis by promoting IgG deposition and inflammatory cell imbalance
por: Liu, T, et al.
Publicado: (2020)

Phosphorylcholine-Primed Dendritic Cells Aggravate the Development of Atherosclerosis in ApoE(−/−) Mice
por: Dong, Qian, et al.
Publicado: (2021)

T cell subsets and immunoglobulin G levels are associated with the infection status of systemic lupus erythematosus patients
por: Wu, Lifen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jfpsm6uoo8mmotspg6r4ggbnth